Impaired vascular reactivity in patients with erectile dysfunction  by Montorsi, Piero et al.
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aore on the History of
rrhythmia in Long QT Syndrome
read with great interest the report by Etheridge et al. (1)
ntitled “A New Oral Therapy for Long QT Syndrome.”
First, I should like to congratulate the investigators for
heir valuable contribution. They found that in patients with
ong QT syndrome due to HERG mutations there was an
mprovement in repolarization in parallel with a normaliz-
ng serum potassium level after oral potassium (and spirono-
actone) administration.
Their final sentence summarizes the present situation as
ollows: “Further studies are warranted to determine
hether they will reduce the incidence of life-threatening
vents in LQTS patients” (1).
We agree with this statement completely, but I would
dditionally draw the attention of the authors of the study
nd the Editorial Comment (2) to the family reported by
amstorp et al. (3) some 40 years ago. Although the
ffected members of the family were slightly hypokalemic,
he administration of potassium led not only to a diminish-
ent of the electrocardiographic abnormalities but also to
essation of the Adams-Stokes attacks.
iklós Csanády, MD, DSc, FESC
niversity of Szeged
nd Department of Medicine and Cardiology Center
orányi fasor 6
zeged, 6720
ungary
-mail: csanady@in2nd.szote.u-szeged.hu
doi:10.1016/j.jacc.2004.06.039
EFERENCES
. Etheridge SP, Compton SJ, Tristani-Firouzi M, Mason JW. A new oral
therapy for long QT syndrome. J Am Coll Cardiol 2003;42:1777–82.
. Bisinov E, Mitchell HJ, January CT. Potassium and long QT syn-
drome. J Am Coll Cardiol 2003;42:1783–4.
. Gamstorp I, Nilsen R, Westling H. Congenital cardiac arrhythmia.
Lancet 1964;2:965.
EPLY
e thank Dr. Csanády for his interest in our report (1) and
or bringing to our attention the report by Gamstorp et al.
2) of a family whose members presented with syncope
ssociated with hypokalemia. Although hypokalemia is a
nown trigger for life-threatening arrhythmia in long QT
yndrome (LQTS) patients, the consistent finding of hypo-
alemia in this family suggests a fundamental abnormality df potassium homeostasis. Hypokalemia is a common fea-
ure of Andersen-Tawil syndrome, triggering both skeletal
uscle paralysis and ventricular arrhythmias. We would like
o emphasize that no subject in our study was hypokalemic
t baseline, and therefore the therapy did not normalize
atients’ serum potassium but, rather, increased their serum
otassium to the upper limits of normal.
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mpaired Vascular Reactivity in
atients With Erectile Dysfunction
n the January 21, 2004 issue of the Journal, Kaiser et al. (1)
eported about endothelial function in patients with erectile
ysfunction (ED) and no vascular risk factors. They found
his group as having significantly less vasodilation to both
schemia (endothelium dependent) and nitroglycerin (endo-
helium independent) stimuli than normal subjects. These
ata led the investigators to conclude there was a peripheral
ascular defect occurring before the development of overt
ascular disease, thus reinforcing the concept of ED as an
arly marker for systemic vascular disease (1).
We believe that one major point needs clarification.
atients were classified as having ED according to the
nternational Index of Erectile Function (IIEF) (2). This
s a 15-item validated self-administered questionnaire that
xplores five domains of sexual function: erectile function,
rgasmic function, sexual desire, intercourse satisfaction,
nd overall satisfaction. Erectile function is specifically
ddressed by six questions, 1, 2, 3, 4, 5, and 15, which form
he so-called “erectile function domain” of the question-
aire. Each question is scored 0 (or 1) to 5 with a minimum
nd maximum score of 1 and 30, respectively. Erectile
ysfunction is defined as any value 26. Below this cut-off
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September 15, 2004:1339–42oint, ED is further defined as mild (22 to 25), mild-to-
oderate (17 to 21), moderate (11 to 16), and severe (10)
3). In the Kaiser et al. (1) study, “normal” subjects had a
ean (SD) score of the IIEF erectile function domain of
1.3 5.3. Assuming a normal distribution, this means that
lmost 80% of normal subjects were below the cut-off for
D, of whom 40% likely had an IIEF score 20 (mild-to-
oderate ED) and 10% 15 (moderate ED). Thus, many
normal” subjects were actually impotent, although to a
esser degree than the true ED group. However, penile color
oppler sonography (the only test that might have further
ifferentiated the two groups) was not performed in normal
ubjects, and this makes any comment conjectural.
If this observation holds true, differences in the vascular
esponse between groups should be reconsidered. In fact, if the
ilation response of “normal” patients with ED is combined
ith dilation response of the real ED group, one would expect
o obtain a higher mean value of percent vascular dilation. For
xample, percent dilation at 60 s after cuff release was 2.4 0.5
ersus 3.7  0.5 in the ED and normal group, respectively. If
ombined, a mean value of 3% would reasonably become
vident. This result, to still be significantly lower, would
equire normals to show an even higher dilation response,
bout 4% to 4.5%. This figure seems to be a rather unusual
esponse after wrist occlusion (4).
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EPLY
r. Montorsi and colleagues express concerns over the
nternational Index of Erectile Function (IIEF)-15 data
resented in our study (1). We inadvertently stated that the
ata presented were the erectile dysfunction (ED) domain
f the IIEF-15, but in fact the data cited in our report were
n average of each individual domain of the IIEF-15. In
esponse to their letter to the editor we went back to the raw
ata and calculated both the ED domain of the IIEF-15
nd the IIEF-5 (an abbreviated version of the IIEF-15).
hese results are presented below.
The IIEF-15 domain consists of six questions (1, 2, 3, 4,
, and 15) with a maximum score of 30 and a cut-off of25
or ED (2). The ED group in our study had an IIEF-15 ED
omain score of 16.1 versus 26.8 for the normal group (p 
.000001).
The IIEF-5 is a validated brief version of the longer
uestionnaire (questions 2, 4, 5, 7, and 15 of the IIEF-15)
3,4). These five questions have been found to discriminate
ost highly between men with and without ED. The
aximum score for the IIEF-5 is 25, with a cut-off of 21
or ED. The ED group in our study had an IIEF-5 of 12.9
ersus 22.3 for the normal group (p  0.000001).
We appreciate the opportunity to clarify this issue. Based
n the results listed above for the ED domain of the
IEF-15 and the IIEF-5, our patients had significant
ymptoms of ED and our control subjects did not have ED.
herefore, the significance of our original observations is
alid, and no further reassessments of the data are war-
anted.
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